Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci

Chemotherapy

Volumn 47, Issue 4, 2001, Pages 250-260

  Baltch, Aldona L ^a,b   Smith, Raymond P ^a   Ritz, William J ^a   Bopp, Lawrence H ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Antibiotic activity; Enterococci; Ketolides; Telithromycin; Vancomycin

Indexed keywords

AMPICILLIN; AZITHROMYCIN; GENTAMICIN; RU 56647; TELITHROMYCIN; VANCOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; DRUG EFFECT; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 0034960859     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048531     Document Type: Article

References (33)

1. Nosocomial enterococcal blood stream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory accuracy
2. Species identification of enterococci isolates from clinical specimens
3. Defining the public health impact of drug resistant Streptococcus pneumoniae: Report of a working group
4. Emerging resistance to antimicrobial agents in grampositive bacteria
5. Antibiotic resistance in Enterococcus species: An update
6. Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen
7. Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): A new class of antibacterials highly potent against macrolide-resistant and susceptible respiratory pathogens
8. Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect
9. Novelties in the field of anti-infectives in 1997
10. The bactericidal activities of HMR 3004, HMR 3647, and erythromycin against gram-positive bacilli and development of resistance
11. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans
12. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes
13. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status
14. In vitro activity of a novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
15. Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis
16. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004
17. Antimicrobial activity of RU-66647, a new ketolide
18. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria
19. A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin
20. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria
21. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria
22. In vitro activity of the new ketolide HMR 3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.
23. Ketolide: New semisynthetic 14-membered ring macrolide
24. HMR 3647, a new ketolide antimicrobial, does not inhibit cytochrome P-450 activity in vitro. 21st International Congress on Chemotherapy, Birmingham, UK
25. The bioavailability of HMR 3647, a new once-daily ketolide antimicrobial, is unaffected by food. 21st International Congress on Chemotherapy, Birmingham, UK
26. The new ketolide, HMR 3647, achieves high and sustained concentrations in white blood cells in man. 21st International Congress on Chemotherapy, Birmingham, UK
27. Interaction between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils
28. The new ketolide HMR 3647 accumulates in the azurophil granules of human polymorphonuclear cells
29. Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State
30. Antimicrobial combinations
31. Post-antibiotic effect